In this episode, host Dr. Mike Nickels welcomes nuclear medicine pioneer Dr. Richard Wahl for an in-depth exploration of alpha-emitting radiopharmaceuticals. Learn where alpha therapy holds the most clinical promise, and what’s needed to bring these powerful agents into routine care. From supply chain hurdles to toxicity management and future clinical applications, this conversation offers expert insight into one of the most exciting—and complex—frontiers in nuclear medicine.